| 000 | 01196 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515122209.0 | ||
| 264 | 0 | _c20080630 | |
| 008 | 200806s 0 0 eng d | ||
| 022 | _a1359-6535 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWiegand, Johannes | |
| 245 | 0 | 0 |
_aShould treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence. _h[electronic resource] |
| 260 |
_bAntiviral therapy _c2008 |
||
| 300 |
_a211-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aEpidemiologic Research Design |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepatitis B _xdrug therapy |
| 650 | 0 | 4 |
_aHepatitis B e Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _xclassification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferons _xpharmacology |
| 650 | 0 | 4 |
_aLamivudine _xpharmacology |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHasenclever, Dirk | |
| 700 | 1 | _aTillmann, Hans L | |
| 773 | 0 |
_tAntiviral therapy _gvol. 13 _gno. 2 _gp. 211-20 |
|
| 999 |
_c17998623 _d17998623 |
||